cached image

Robert H. Perry, PhD - Publications

Affiliations: 
Neuropathology University of Newcastle, Newcastle upon Tyne, England, United Kingdom 
Area:
http://www.researchprofiles.collexis.com/jad/expert.asp?u_id=34
Website:
http://www.ncl.ac.uk/biomedicine/research/groups/profile/robert.perry

245 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Hase Y, Polvikoski TM, Firbank MJ, Craggs LJ, Hawthorne E, Platten C, Stevenson W, Deramecourt V, Ballard C, Kenny RA, Perry RH, Ince P, Carare RO, Allan LM, Horsburgh K, et al. Small Vessel Disease Pathological Changes in Neurodegenerative and Vascular Dementias concomitant with Autonomic Dysfunction. Brain Pathology (Zurich, Switzerland). PMID 31357238 DOI: 10.1111/Bpa.12769  0.432
2018 Petyuk VA, Chang R, Ramirez-Restrepo M, Beckmann ND, Henrion MYR, Piehowski PD, Zhu K, Wang S, Clarke J, Huentelman MJ, Xie F, Andreev V, Engel A, Guettoche T, Navarro L, ... ... Perry RH, et al. The human brainome: network analysis identifies HSPA2 as a novel Alzheimer's disease target. Brain : a Journal of Neurology. PMID 30137212 DOI: 10.1093/Brain/Awy215  0.366
2015 Tiraboschi P, Attems J, Thomas A, Brown A, Jaros E, Lett DJ, Ossola M, Perry RH, Ramsay L, Walker L, McKeith IG. Clinicians' ability to diagnose dementia with Lewy bodies is not affected by β-amyloid load. Neurology. 84: 496-9. PMID 25552579 DOI: 10.1212/Wnl.0000000000001204  0.328
2013 Mukaetova-Ladinska EB, Andras A, Milne J, Abdel-All Z, Borr I, Jaros E, Perry RH, Honer WG, Cleghorn A, Doherty J, McIntosh G, Perry EK, Kalaria RN, McKeith IG. Synaptic proteins and choline acetyltransferase loss in visual cortex in dementia with Lewy bodies. Journal of Neuropathology and Experimental Neurology. 72: 53-60. PMID 23242284 DOI: 10.1097/Nen.0B013E31827C5710  0.393
2012 Baborie A, Griffiths TD, Jaros E, Momeni P, McKeith IG, Burn DJ, Keir G, Larner AJ, Mann DM, Perry R. Frontotemporal dementia in elderly individuals. Archives of Neurology. 69: 1052-60. PMID 22529248 DOI: 10.1001/Archneurol.2011.3323  0.384
2012 Perry EK, Johnson M, Ekonomou A, Perry RH, Ballard C, Attems J. Neurogenic abnormalities in Alzheimer's disease differ between stages of neurogenesis and are partly related to cholinergic pathology. Neurobiology of Disease. 47: 155-62. PMID 22504537 DOI: 10.1016/J.Nbd.2012.03.033  0.362
2012 Burton EJ, Mukaetova-Ladinska EB, Perry RH, Jaros E, Barber R, O'Brien JT. Quantitative neurodegenerative pathology does not explain the degree of hippocampal atrophy on MRI in degenerative dementia. International Journal of Geriatric Psychiatry. 27: 1267-74. PMID 22383167 DOI: 10.1002/Gps.3774  0.396
2012 Deramecourt V, Slade JY, Oakley AE, Perry RH, Ince PG, Maurage CA, Kalaria RN. Staging and natural history of cerebrovascular pathology in dementia. Neurology. 78: 1043-50. PMID 22377814 DOI: 10.1212/Wnl.0B013E31824E8E7F  0.408
2012 Kalaria RN, Perry RH, O'Brien J, Jaros E. Atheromatous disease in small intracerebral vessels, microinfarcts and dementia. Neuropathology and Applied Neurobiology. 38: 505-8. PMID 22376046 DOI: 10.1111/J.1365-2990.2012.01264.X  0.38
2012 Ekonomou A, Johnson M, Perry RH, Perry EK, Kalaria RN, Minger SL, Ballard CG. Increased neural progenitors in individuals with cerebral small vessel disease. Neuropathology and Applied Neurobiology. 38: 344-53. PMID 21988073 DOI: 10.1111/J.1365-2990.2011.01224.X  0.409
2012 Burton EJ, Mukaetova-Ladinska EB, Perry RH, Jaros E, Barber R, O'Brien JT. Neuropathological correlates of volumetric MRI in autopsy-confirmed Lewy body dementia. Neurobiology of Aging. 33: 1228-36. PMID 21353336 DOI: 10.1016/J.Neurobiolaging.2010.12.015  0.379
2011 Armstrong RA, Gearing M, Bigio EH, Cruz-Sanchez FF, Duyckaerts C, Mackenzie IR, Perry RH, Skullerud K, Yokoo H, Cairns NJ. Spatial patterns of FUS-immunoreactive neuronal cytoplasmic inclusions (NCI) in neuronal intermediate filament inclusion disease (NIFID). Journal of Neural Transmission (Vienna, Austria : 1996). 118: 1651-7. PMID 21792670 DOI: 10.1007/S00702-011-0690-X  0.311
2011 Mackenzie IR, Neumann M, Baborie A, Sampathu DM, Du Plessis D, Jaros E, Perry RH, Trojanowski JQ, Mann DM, Lee VM. A harmonized classification system for FTLD-TDP pathology. Acta Neuropathologica. 122: 111-3. PMID 21644037 DOI: 10.1007/S00401-011-0845-8  0.33
2011 Snowden JS, Hu Q, Rollinson S, Halliwell N, Robinson A, Davidson YS, Momeni P, Baborie A, Griffiths TD, Jaros E, Perry RH, Richardson A, Pickering-Brown SM, Neary D, Mann DM. The most common type of FTLD-FUS (aFTLD-U) is associated with a distinct clinical form of frontotemporal dementia but is not related to mutations in the FUS gene. Acta Neuropathologica. 122: 99-110. PMID 21424531 DOI: 10.1007/S00401-011-0816-0  0.377
2011 Baborie A, Griffiths TD, Jaros E, McKeith IG, Burn DJ, Richardson A, Ferrari R, Moreno J, Momeni P, Duplessis D, Pal P, Rollinson S, Pickering-Brown S, Thompson JC, Neary D, ... ... Perry R, et al. Pathological correlates of frontotemporal lobar degeneration in the elderly. Acta Neuropathologica. 121: 365-71. PMID 20978901 DOI: 10.1007/S00401-010-0765-Z  0.348
2011 Armstrong RA, Gearing M, Bigio EH, Cruz-Sanchez FF, Duyckaerts C, Mackenzie IR, Perry RH, Skullerud K, Yokoo H, Cairns NJ. The spectrum and severity of FUS-immunoreactive inclusions in the frontal and temporal lobes of ten cases of neuronal intermediate filament inclusion disease. Acta Neuropathologica. 121: 219-28. PMID 20886222 DOI: 10.1007/S00401-010-0753-3  0.345
2011 Johnson M, Ekonomou A, Hobbs C, Ballard CG, Perry RH, Perry EK. Neurogenic marker abnormalities in the hippocampus in dementia with Lewy bodies. Hippocampus. 21: 1126-36. PMID 20665591 DOI: 10.1002/Hipo.20826  0.35
2011 Bernstein HG, Johnson M, Perry RH, LeBeau FE, Dobrowolny H, Bogerts B, Perry EK. Partial loss of parvalbumin-containing hippocampal interneurons in dementia with Lewy bodies. Neuropathology : Official Journal of the Japanese Society of Neuropathology. 31: 1-10. PMID 20487308 DOI: 10.1111/J.1440-1789.2010.01117.X  0.351
2011 Ekonomou A, Ballard CG, Pathmanaban ON, Perry RH, Perry EK, Kalaria RN, Minger SL. Increased neural progenitors in vascular dementia. Neurobiology of Aging. 32: 2152-61. PMID 20138403 DOI: 10.1016/J.Neurobiolaging.2010.01.007  0.319
2011 Burton E, Mukaetova-Ladinska E, Perry R, Jaros E, Barber R, O'Brien J. Medial temporal lobe volumes on MRI and neuropathology in autopsy-confirmed Lewy body dementia Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.026  0.346
2010 Ihara M, Polvikoski TM, Hall R, Slade JY, Perry RH, Oakley AE, Englund E, O'Brien JT, Ince PG, Kalaria RN. Quantification of myelin loss in frontal lobe white matter in vascular dementia, Alzheimer's disease, and dementia with Lewy bodies. Acta Neuropathologica. 119: 579-89. PMID 20091409 DOI: 10.1007/S00401-009-0635-8  0.371
2009 Elliott MS, Ballard CG, Kalaria RN, Perry R, Hortobágyi T, Francis PT. Increased binding to 5-HT1A and 5-HT2A receptors is associated with large vessel infarction and relative preservation of cognition. Brain : a Journal of Neurology. 132: 1858-65. PMID 19433439 DOI: 10.1093/Brain/Awp069  0.369
2009 Chalmers KA, Wilcock GK, Vinters HV, Perry EK, Perry R, Ballard CG, Love S. Cholinesterase inhibitors may increase phosphorylated tau in Alzheimer's disease. Journal of Neurology. 256: 717-20. PMID 19240967 DOI: 10.1007/S00415-009-5000-2  0.387
2009 Burton EJ, Barber R, Mukaetova-Ladinska EB, Robson J, Perry RH, Jaros E, Kalaria RN, O'Brien JT. Medial temporal lobe atrophy on MRI differentiates Alzheimer's disease from dementia with Lewy bodies and vascular cognitive impairment: a prospective study with pathological verification of diagnosis. Brain : a Journal of Neurology. 132: 195-203. PMID 19022858 DOI: 10.1093/Brain/Awn298  0.448
2008 Sharp SI, Ballard CG, Ziabreva I, Piggott MA, Perry RH, Perry EK, Aarsland D, Ehrt U, Larsen JP, Francis PT. Cortical serotonin 1A receptor levels are associated with depression in patients with dementia with Lewy bodies and Parkinson's disease dementia. Dementia and Geriatric Cognitive Disorders. 26: 330-8. PMID 18841018 DOI: 10.1159/000161058  0.312
2008 Mukaetova-Ladinska EB, Milne J, Andras A, Abdel-All Z, Cerejeira J, Greally E, Robson J, Jaros E, Perry R, McKeith IG, Brayne C, Xuereb J, Cleghorn A, Doherty J, McIntosh G, et al. Alpha- and gamma-synuclein proteins are present in cerebrospinal fluid and are increased in aged subjects with neurodegenerative and vascular changes. Dementia and Geriatric Cognitive Disorders. 26: 32-42. PMID 18577885 DOI: 10.1159/000141039  0.376
2008 MacInnes N, Iravani MM, Perry E, Piggott M, Perry R, Jenner P, Ballard C. Proteasomal abnormalities in cortical Lewy body disease and the impact of proteasomal inhibition within cortical and cholinergic systems. Journal of Neural Transmission (Vienna, Austria : 1996). 115: 869-78. PMID 18401540 DOI: 10.1007/S00702-008-0027-6  0.404
2008 Mulugeta E, Molina-Holgado F, Elliott MS, Hortobagyi T, Perry R, Kalaria RN, Ballard CG, Francis PT. Inflammatory mediators in the frontal lobe of patients with mixed and vascular dementia. Dementia and Geriatric Cognitive Disorders. 25: 278-86. PMID 18303264 DOI: 10.1159/000118633  0.365
2008 Burton EJ, Barber R, Mukaetova-Ladinska EB, Perry R, O'Brien JT. AbstractPoster presentation: Sunday posterP1-322: Pathologic diagnosis of Alzheimer's disease contributes more to medial temporal lobe atrophy than measures of pathology in demented and nondemented subjects Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.913  0.398
2008 Burton EJ, Barber R, Mukaetova-Ladinska EB, Perry R, O'Brien JT. IC-P1-006: Pathologic diagnosis of Alzheimer's disease contributes more to medial temporal lobe atrophy than measures of pathology in demented and non-demented subjects Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.019  0.334
2007 Piggott MA, Ballard CG, Rowan E, Holmes C, McKeith IG, Jaros E, Perry RH, Perry EK. Selective loss of dopamine D2 receptors in temporal cortex in dementia with Lewy bodies, association with cognitive decline. Synapse (New York, N.Y.). 61: 903-11. PMID 17663455 DOI: 10.1002/Syn.20441  0.387
2007 Ziabreva I, Ballard C, Johnson M, Larsen JP, McKeith I, Perry R, Aarsland D, Perry E. Loss of Musashi1 in Lewy body dementia associated with cholinergic deficit. Neuropathology and Applied Neurobiology. 33: 586-590. PMID 17573814 DOI: 10.1111/J.1365-2990.2007.00848.X  0.353
2007 Margallo-Lana ML, Moore PB, Kay DW, Perry RH, Reid BE, Berney TP, Tyrer SP. Fifteen-year follow-up of 92 hospitalized adults with Down's syndrome: incidence of cognitive decline, its relationship to age and neuropathology. Journal of Intellectual Disability Research : Jidr. 51: 463-77. PMID 17493029 DOI: 10.1111/J.1365-2788.2006.00902.X  0.376
2007 Walker Z, Jaros E, Walker RW, Lee L, Costa DC, Livingston G, Ince PG, Perry R, McKeith I, Katona CL. Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy. Journal of Neurology, Neurosurgery, and Psychiatry. 78: 1176-81. PMID 17353255 DOI: 10.1136/Jnnp.2006.110122  0.379
2007 Myers AJ, Pittman AM, Zhao AS, Rohrer K, Kaleem M, Marlowe L, Lees A, Leung D, McKeith IG, Perry RH, Morris CM, Trojanowski JQ, Clark C, Karlawish J, Arnold S, et al. The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts. Neurobiology of Disease. 25: 561-70. PMID 17174556 DOI: 10.1016/J.Nbd.2006.10.018  0.354
2007 Piggott MA, Ballard CG, Dickinson HO, McKeith IG, Perry RH, Perry EK. Thalamic D2 receptors in dementia with Lewy bodies, Parkinson's disease, and Parkinson's disease dementia. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 10: 231-44. PMID 16448581 DOI: 10.1017/S146114570600647X  0.381
2006 Ballard C, Ziabreva I, Perry R, Larsen JP, O'Brien J, McKeith I, Perry E, Aarsland D. Differences in neuropathologic characteristics across the Lewy body dementia spectrum. Neurology. 67: 1931-1934. PMID 17159096 DOI: 10.1212/01.Wnl.0000249130.63615.Cc  0.445
2006 Mackenzie IR, Baborie A, Pickering-Brown S, Du Plessis D, Jaros E, Perry RH, Neary D, Snowden JS, Mann DM. Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: classification and relation to clinical phenotype. Acta Neuropathologica. 112: 539-49. PMID 17021754 DOI: 10.1007/S00401-006-0138-9  0.372
2006 Ziabreva I, Perry E, Perry R, Minger SL, Ekonomou A, Przyborski S, Ballard C. Altered neurogenesis in Alzheimer's disease Journal of Psychosomatic Research. 61: 311-316. PMID 16938507 DOI: 10.1016/J.Jpsychores.2006.07.017  0.41
2006 Polvikoski T, Kalaria RN, Perry R, Miller V, Kenny RA. Carotid sinus hypersensitivity associated with focal alpha-synucleinopathy of the autonomic nervous system. Journal of Neurology, Neurosurgery, and Psychiatry. 77: 1064-6. PMID 16914754 DOI: 10.1136/Jnnp.2005.083550  0.316
2006 Betts J, Jaros E, Perry RH, Schaefer AM, Taylor RW, Abdel-All Z, Lightowlers RN, Turnbull DM. Molecular neuropathology of MELAS: level of heteroplasmy in individual neurones and evidence of extensive vascular involvement. Neuropathology and Applied Neurobiology. 32: 359-73. PMID 16866982 DOI: 10.1111/J.1365-2990.2006.00731.X  0.304
2006 Gotti C, Moretti M, Bohr I, Ziabreva I, Vailati S, Longhi R, Riganti L, Gaimarri A, McKeith IG, Perry RH, Aarsland D, Larsen JP, Sher E, Beattie R, Clementi F, et al. Selective nicotinic acetylcholine receptor subunit deficits identified in Alzheimer's disease, Parkinson's disease and dementia with Lewy bodies by immunoprecipitation. Neurobiology of Disease. 23: 481-9. PMID 16759874 DOI: 10.1016/J.Nbd.2006.04.005  0.352
2006 Bender A, Krishnan KJ, Morris CM, Taylor GA, Reeve AK, Perry RH, Jaros E, Hersheson JS, Betts J, Klopstock T, Taylor RW, Turnbull DM. High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nature Genetics. 38: 515-7. PMID 16604074 DOI: 10.1038/Ng1769  0.308
2006 Lewis H, Beher D, Cookson N, Oakley A, Piggott M, Morris CM, Jaros E, Perry R, Ince P, Kenny RA, Ballard CG, Shearman MS, Kalaria RN. Quantification of Alzheimer pathology in ageing and dementia: age-related accumulation of amyloid-beta(42) peptide in vascular dementia. Neuropathology and Applied Neurobiology. 32: 103-18. PMID 16599940 DOI: 10.1111/J.1365-2990.2006.00696.X  0.348
2006 Sahin HA, Emre M, Ziabreva I, Perry E, Celasun B, Perry R. The distribution pattern of pathology and cholinergic deficits in amygdaloid complex in Alzheimer's disease and dementia with Lewy bodies. Acta Neuropathologica. 111: 115-25. PMID 16468020 DOI: 10.1007/S00401-005-0003-2  0.412
2006 Pimlott SL, Piggott M, Ballard C, McKeith I, Perry R, Kometa S, Owens J, Wyper D, Perry E. Thalamic nicotinic receptors implicated in disturbed consciousness in dementia with Lewy bodies. Neurobiology of Disease. 21: 50-6. PMID 16023355 DOI: 10.1016/J.Nbd.2005.06.008  0.362
2006 Momeni P, Cairns NJ, Perry RH, Bigio EH, Gearing M, Singleton AB, Hardy J. Mutation analysis of patients with neuronal intermediate filament inclusion disease (NIFID). Neurobiology of Aging. 27: 778.e1-778.e6. PMID 16005115 DOI: 10.1016/J.Neurobiolaging.2005.03.030  0.355
2006 Ziabreva I, Ballard CG, Aarsland D, Larsen JP, McKeith IG, Perry RH, Perry EK. Lewy body disease: thalamic cholinergic activity related to dementia and parkinsonism. Neurobiology of Aging. 27: 433-8. PMID 15913843 DOI: 10.1016/J.Neurobiolaging.2005.02.004  0.391
2005 Aarsland D, Perry R, Brown A, Larsen JP, Ballard C. Neuropathology of dementia in Parkinson's disease: a prospective, community-based study. Annals of Neurology. 58: 773-6. PMID 16240351 DOI: 10.1002/Ana.20635  0.394
2005 McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, ... ... Perry RH, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 65: 1863-72. PMID 16237129 DOI: 10.1212/01.Wnl.0000187889.17253.B1  0.387
2005 Court JA, Johnson M, Religa D, Keverne J, Kalaria R, Jaros E, McKeith IG, Perry R, Naslund J, Perry EK. Attenuation of Abeta deposition in the entorhinal cortex of normal elderly individuals associated with tobacco smoking. Neuropathology and Applied Neurobiology. 31: 522-35. PMID 16150123 DOI: 10.1111/J.1365-2990.2005.00674.X  0.331
2005 Ballard CG, Perry RH, McKeith IG, Perry EK. Neuroleptics are associated with more severe tangle pathology in dementia with Lewy bodies. International Journal of Geriatric Psychiatry. 20: 872-5. PMID 16116579 DOI: 10.1002/Gps.1378  0.438
2005 Teaktong T, Piggott MA, Mckeith IG, Perry RH, Ballard CG, Perry EK. Muscarinic M2 and M4 receptors in anterior cingulate cortex: relation to neuropsychiatric symptoms in dementia with Lewy bodies. Behavioural Brain Research. 161: 299-305. PMID 15922057 DOI: 10.1016/J.Bbr.2005.02.019  0.304
2005 Ballard C, Morris C, Kalaria R, McKeith I, Perry R, Perry E. The k variant of the butyrylcholinesterase gene is associated with reduced phosphorylation of tau in dementia patients. Dementia and Geriatric Cognitive Disorders. 19: 357-60. PMID 15802910 DOI: 10.1159/000084705  0.39
2005 Pyle A, Foltynie T, Tiangyou W, Lambert C, Keers SM, Allcock LM, Davison J, Lewis SJ, Perry RH, Barker R, Burn DJ, Chinnery PF. Mitochondrial DNA haplogroup cluster UKJT reduces the risk of PD. Annals of Neurology. 57: 564-7. PMID 15786469 DOI: 10.1002/Ana.20417  0.345
2005 Aarsland D, Perry R, Larsen JP, McKeith IG, O'Brien JT, Perry EK, Burn D, Ballard CG. Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias. The Journal of Clinical Psychiatry. 66: 633-637. DOI: 10.4088/Jcp.V66N0514  0.405
2004 Aarsland D, Andersen K, Larsen JP, Perry R, Wentzel-Larsen T, Lolk A, Kragh-Sørensen P. The Rate of Cognitive Decline in Parkinson Disease Jama Neurology. 61: 1906-1911. PMID 15596611 DOI: 10.1001/Archneur.61.12.1906  0.336
2004 Ray M, Bohr I, McIntosh JM, Ballard C, McKeith I, Chalon S, Guilloteau D, Perry R, Perry E, Court JA, Piggott M. Involvement of alpha6/alpha3 neuronal nicotinic acetylcholine receptors in neuropsychiatric features of Dementia with Lewy bodies: [(125)I]-alpha-conotoxin MII binding in the thalamus and striatum. Neuroscience Letters. 372: 220-5. PMID 15542244 DOI: 10.1016/J.Neulet.2004.09.042  0.32
2004 Kalaria RN, Kenny RA, Ballard CG, Perry R, Ince P, Polvikoski T. Towards defining the neuropathological substrates of vascular dementia. Journal of the Neurological Sciences. 226: 75-80. PMID 15537525 DOI: 10.1016/J.Jns.2004.09.019  0.395
2004 Cairns NJ, Grossman M, Arnold SE, Burn DJ, Jaros E, Perry RH, Duyckaerts C, Stankoff B, Pillon B, Skullerud K, Cruz-Sanchez FF, Bigio EH, Mackenzie IR, Gearing M, Juncos JL, et al. Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease. Neurology. 63: 1376-84. PMID 15505152 DOI: 10.1212/01.Wnl.0000139809.16817.Dd  0.373
2004 Busby J, O'Brien KK, Gibson AM, McKeith IG, Perry RH, Hardy JA, Singleton AB, Morris CM. Dementia with Lewy bodies: no association of polymorphisms in the human synphilin gene. Neurogenetics. 5: 251-2. PMID 15490287 DOI: 10.1007/S10048-004-0188-X  0.306
2004 Teaktong T, Graham AJ, Court JA, Perry RH, Jaros E, Johnson M, Hall R, Perry EK. Nicotinic acetylcholine receptor immunohistochemistry in Alzheimer's disease and dementia with Lewy bodies: differential neuronal and astroglial pathology. Journal of the Neurological Sciences. 225: 39-49. PMID 15465084 DOI: 10.1016/J.Jns.2004.06.015  0.408
2004 Johnson J, Hague SM, Hanson M, Gibson A, Wilson KE, Evans EW, Singleton AA, McInerney-Leo A, Nussbaum RL, Hernandez DG, Gallardo M, McKeith IG, Burn DJ, Ryu M, Hellstrom O, ... ... Perry RH, et al. SNCA multiplication is not a common cause of Parkinson disease or dementia with Lewy bodies. Neurology. 63: 554-6. PMID 15304594 DOI: 10.1212/01.Wnl.0000133401.09043.44  0.351
2004 Cairns NJ, Uryu K, Bigio EH, Mackenzie IR, Gearing M, Duyckaerts C, Yokoo H, Nakazato Y, Jaros E, Perry RH, Arnold SE, Lee VM, Trojanowski JQ. alpha-Internexin aggregates are abundant in neuronal intermediate filament inclusion disease (NIFID) but rare in other neurodegenerative diseases. Acta Neuropathologica. 108: 213-23. PMID 15170578 DOI: 10.1007/S00401-004-0882-7  0.353
2004 Cairns NJ, Zhukareva V, Uryu K, Zhang B, Bigio E, Mackenzie IR, Gearing M, Duyckaerts C, Yokoo H, Nakazato Y, Jaros E, Perry RH, Lee VM, Trojanowski JQ. alpha-internexin is present in the pathological inclusions of neuronal intermediate filament inclusion disease. The American Journal of Pathology. 164: 2153-61. PMID 15161649 DOI: 10.1016/S0002-9440(10)63773-X  0.37
2004 Walker Z, Costa DC, Walker RW, Lee L, Livingston G, Jaros E, Perry R, McKeith I, Katona CL. Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease: a comparison. Neurology. 62: 1568-72. PMID 15136683 DOI: 10.1212/01.Wnl.0000123248.39847.1D  0.317
2004 Ballard CG, Jacoby R, Del Ser T, Khan MN, Munoz DG, Holmes C, Nagy Z, Perry EK, Joachim C, Jaros E, O'Brien JT, Perry RH, McKeith IG. Neuropathological substrates of psychiatric symptoms in prospectively studied patients with autopsy-confirmed dementia with lewy bodies. The American Journal of Psychiatry. 161: 843-9. PMID 15121649 DOI: 10.1176/Appi.Ajp.161.5.843  0.421
2004 Cairns NJ, Jaros E, Perry RH, Armstrong RA. Temporal lobe pathology of human patients with neurofilament inclusion disease. Neuroscience Letters. 354: 245-7. PMID 14700742 DOI: 10.1016/J.Neulet.2003.10.020  0.362
2004 Perry EK, Perry RH. Neurochemistry of consciousness: cholinergic pathologies in the human brain. Progress in Brain Research. 145: 287-99. PMID 14650923 DOI: 10.1016/S0079-6123(03)45020-6  0.428
2004 Pimlott SL, Piggott M, Owens J, Greally E, Court JA, Jaros E, Perry RH, Perry EK, Wyper D. Nicotinic acetylcholine receptor distribution in Alzheimer's disease, dementia with Lewy bodies, Parkinson's disease, and vascular dementia: in vitro binding study using 5-[(125)i]-a-85380. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 108-16. PMID 12955099 DOI: 10.1038/Sj.Npp.1300302  0.433
2004 Momeni P, Cairns N, Perry R, Jaros E, Singleton AB, Hardy J. P4-164 Molecular study of dementia with neurofilament inclusions Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)81722-6  0.318
2004 Cairns NJ, Jaros E, Perry RH, Armstrong RA. Laminar distribution of neurofilament inclusions and swollen achromatic neurons in neurofilament inclusion disease (NID) Neuroscience Research Communications. 34: 104-111. DOI: 10.1002/Nrc.20004  0.307
2003 Perry EK, Kilford L, Lees AJ, Burn DJ, Perry RH. Increased Alzheimer pathology in Parkinson's disease related to antimuscarinic drugs. Annals of Neurology. 54: 235-8. PMID 12891676 DOI: 10.1002/Ana.10639  0.395
2003 Stone J, Griffiths TD, Rastogi S, Perry RH, Cleland PG. Non-Picks frontotemporal dementia imitating schizophrenia in a 22-year-old man. Journal of Neurology. 250: 369-70. PMID 12749325 DOI: 10.1007/S00415-003-0989-0  0.355
2003 Piggott MA, Owens J, O'Brien J, Colloby S, Fenwick J, Wyper D, Jaros E, Johnson M, Perry RH, Perry EK. Muscarinic receptors in basal ganglia in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease. Journal of Chemical Neuroanatomy. 25: 161-73. PMID 12706204 DOI: 10.1016/S0891-0618(03)00002-4  0.382
2003 Cairns NJ, Perry RH, Jaros E, Burn D, McKeith IG, Lowe JS, Holton J, Rossor MN, Skullerud K, Duyckaerts C, Cruz-Sanchez FF, Lantos PL. Patients with a novel neurofilamentopathy: dementia with neurofilament inclusions. Neuroscience Letters. 341: 177-80. PMID 12697277 DOI: 10.1016/S0304-3940(03)00100-9  0.404
2003 McKeith IG, Burn DJ, Ballard CG, Collerton D, Jaros E, Morris CM, McLaren A, Perry EK, Perry R, Piggott MA, O'Brien JT. Dementia with Lewy bodies. Seminars in Clinical Neuropsychiatry. 8: 46-57. PMID 12567332 DOI: 10.1053/Scnp.2003.50006  0.386
2003 Teaktong T, Graham A, Court J, Perry R, Jaros E, Johnson M, Hall R, Perry E. Alzheimer's disease is associated with a selective increase in α7 nicotinic acetylcholine receptor immunoreactivity in astrocytes Glia. 41: 207-211. PMID 12509811 DOI: 10.1002/Glia.10132  0.414
2003 Thomas AJ, Perry R, Kalaria RN, Oakley A, McMeekin W, O'Brien JT. Neuropathological evidence for ischemia in the white matter of the dorsolateral prefrontal cortex in late-life depression. International Journal of Geriatric Psychiatry. 18: 7-13. PMID 12497551 DOI: 10.1002/Gps.720  0.302
2002 SantaCruz KS, Walker Z, Swagerty D, Piggott MA, Ryo-Yang M, McKeith IG, Raghavan R, Jaros E, Perry RH. Clinical presentations in monozygotic twins with dementia with Lewy bodies. Journal of the American Medical Directors Association. 3: 175-9. PMID 12807662 DOI: 10.1016/S1525-8610(04)70461-2  0.417
2002 Thomas AJ, Perry R, Barber R, Kalaria RN, O'Brien JT. Pathologies and pathological mechanisms for white matter hyperintensities in depression. Annals of the New York Academy of Sciences. 977: 333-9. PMID 12480770 DOI: 10.1111/J.1749-6632.2002.Tb04835.X  0.349
2002 Martin-Ruiz C, Lawrence S, Piggott M, Kuryatov A, Lindstrom J, Gotti C, Cookson MR, Perry RH, Jaros E, Perry EK, Court JA. Nicotinic receptors in the putamen of patients with dementia with Lewy bodies and Parkinson's disease: relation to changes in alpha-synuclein expression. Neuroscience Letters. 335: 134-8. PMID 12459516 DOI: 10.1016/S0304-3940(02)01183-7  0.343
2002 Ballard CG, Court JA, Piggott M, Johnson M, O'Brien J, McKeith I, Holmes C, Lantos P, Jaros E, Perry R, Perry E. Disturbances of consciousness in dementia with Lewy bodies associated with alteration in nicotinic receptor binding in the temporal cortex. Consciousness and Cognition. 11: 461-74. PMID 12435378 DOI: 10.1016/S1053-8100(02)00013-2  0.358
2002 Singleton AB, Wharton A, O'Brien KK, Walker MP, McKeith IG, Ballard CG, O'Brien J, Perry RH, Ince PG, Edwardson JA, Morris CM. Clinical and neuropathological correlates of apolipoprotein E genotype in dementia with Lewy bodies. Dementia and Geriatric Cognitive Disorders. 14: 167-75. PMID 12411758 DOI: 10.1159/000066022  0.399
2002 Ballard C, Johnson M, Piggott M, Perry R, O'Brien J, Rowan E, Perry E, Lantos P, Cairns N, Holmes C. A positive association between 5HT re-uptake binding sites and depression in dementia with Lewy bodies. Journal of Affective Disorders. 69: 219-23. PMID 12103469 DOI: 10.1016/S0165-0327(00)00375-X  0.316
2002 Lee M, Martin‐Ruiz C, Graham A, Court J, Jaros E, Perry R, Iversen P, Bauman M, Perry E. Nicotinic receptor abnormalities in the cerebellar cortex in autism. Brain. 125: 1483-1495. PMID 12076999 DOI: 10.1093/Brain/Awf160  0.308
2002 Court J, Spurden D, Lloyd S, McKeith I, Ballard C, Cairns N, Kerwin R, Perry R, Perry E. Neuronal nicotinic receptors in dementia with Lewy bodies and schizophrenia: alpha-bungarotoxin and nicotine binding in the thalamus. Journal of Neurochemistry. 73: 1590-1597. PMID 10501205 DOI: 10.1046/J.1471-4159.1999.0731590.X  0.315
2002 Teahan O, Slade JY, Perry RH, Ballard CG, Kalaria RN. White matter pathology in Alzheimer's disease and vascular dementia: quantification by amyloid-beta precursor protein immunocytochemistry Neuropathology and Applied Neurobiology. 28: 168-168. DOI: 10.1046/J.1365-2990.2002.39286_52.X  0.406
2001 Court JA, Ballard CG, Piggott MA, Johnson M, O'Brien JT, Holmes C, Cairns N, Lantos P, Perry RH, Jaros E, Perry EK. Visual hallucinations are associated with lower alpha bungarotoxin binding in dementia with Lewy bodies. Pharmacology, Biochemistry, and Behavior. 70: 571-9. PMID 11796155 DOI: 10.1016/S0091-3057(01)00644-X  0.365
2001 Gilbertson R, Wickramasinghe C, Hernan R, Balaji V, Hunt D, Jones-Wallace D, Crolla J, Perry R, Lunec J, Pearson A, Ellison D. Clinical and molecular stratification of disease risk in medulloblastoma. British Journal of Cancer. 85: 705-712. PMID 11531256 DOI: 10.1054/Bjoc.2001.1987  0.307
2001 Aarsland D, Ballard C, McKeith I, Perry RH, Larsen JP. Comparison of extrapyramidal signs in dementia with Lewy bodies and Parkinson's disease. The Journal of Neuropsychiatry and Clinical Neurosciences. 13: 374-9. PMID 11514644 DOI: 10.1176/Appi.Neuropsych.13.3.374  0.364
2001 Marutle A, Zhang X, Court J, Piggott M, Johnson M, Perry R, Perry E, Nordberg A. Laminar distribution of nicotinic receptor subtypes in cortical regions in schizophrenia. Journal of Chemical Neuroanatomy. 22: 115-26. PMID 11470559 DOI: 10.1016/S0891-0618(01)00117-X  0.3
2001 Perry EK, Lee ML, Martin-Ruiz CM, Court JA, Volsen SG, Merrit J, Folly E, Iversen PE, Bauman ML, Perry RH, Wenk GL. Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain. The American Journal of Psychiatry. 158: 1058-66. PMID 11431227 DOI: 10.1176/Appi.Ajp.158.7.1058  0.344
2001 Lloyd AJ, Grace JB, Jaros E, Perry RH, Fairbairn AF, Swann AG, O'Brien JT, McKeith IG. Depression in late life, cognitive decline and white matter pathology in two clinico-pathologically investigated cases. International Journal of Geriatric Psychiatry. 16: 281-7. PMID 11288162 DOI: 10.1002/Gps.328  0.331
2001 Kalaria RN, Ballard CG, Ince PG, Kenny RA, McKeith IG, Morris CM, O'Brien JT, Perry EK, Perry RH, Edwardson JA. Multiple substrates of late-onset dementia: implications for brain protection. Novartis Foundation Symposium. 235: 49-60; discussion 60. PMID 11280033  0.331
2001 O'Brien J, Thomas A, Ballard C, Brown A, Ferrier N, Jaros E, Perry R. Cognitive impairment in depression is not associated with neuropathologic evidence of increased vascular or Alzheimer-type pathology. Biological Psychiatry. 49: 130-6. PMID 11164759 DOI: 10.1016/S0006-3223(00)00944-6  0.311
2001 Thomas AJ, Ferrier IN, Kalaria RN, Perry RH, Brown A, O'Brien JT. A neuropathological study of vascular factors in late-life depression. Journal of Neurology, Neurosurgery, and Psychiatry. 70: 83-7. PMID 11118253 DOI: 10.1136/Jnnp.70.1.83  0.362
2000 Martin-Ruiz C, Court J, Lee M, Piggott M, Johnson M, Ballard C, Kalaria R, Perry R, Perry E. Nicotinic receptors in dementia of Alzheimer, Lewy body and vascular types. Acta Neurologica Scandinavica. Supplementum. 176: 34-41. PMID 11261803 DOI: 10.1034/J.1600-0404.2000.00305.X  0.41
2000 Singleton AB, Hall R, Ballard CG, Perry RH, Xuereb JH, Rubinsztein DC, Tysoe C, Matthews P, Cordell B, Kumar-Singh S, De Jonghe C, Cruts M, van Broeckhoven C, Morris CM. Pathology of early-onset Alzheimer's disease cases bearing the Thr113-114ins presenilin-1 mutation. Brain : a Journal of Neurology. 123: 2467-74. PMID 11099448 DOI: 10.1093/Brain/123.12.2467  0.38
2000 Martin-Ruiz CM, Piggott M, Gotti C, Lindstrom J, Mendelow AD, Siddique MS, Perry RH, Perry EK, Court JA. Alpha and beta nicotinic acetylcholine receptors subunits and synaptophysin in putamen from Parkinson's disease. Neuropharmacology. 39: 2830-9. PMID 11044753 DOI: 10.1016/S0028-3908(00)00110-6  0.337
2000 Chinnery PF, Taylor GA, Howell N, Andrews RM, Morris CM, Taylor RW, McKeith IG, Perry RH, Edwardson JA, Turnbull DM. Mitochondrial DNA haplogroups and susceptibility to AD and dementia with Lewy bodies. Neurology. 55: 302-4. PMID 10908912 DOI: 10.1212/Wnl.55.2.302  0.342
2000 Ballard C, O'Brien J, Swann A, Neill D, Lantos P, Holmes C, Burn D, Ince P, Perry R, McKeith I. One year follow-up of parkinsonism in dementia with Lewy bodies. Dementia and Geriatric Cognitive Disorders. 11: 219-22. PMID 10867448 DOI: 10.1159/000017240  0.407
2000 Court JA, Piggott MA, Lloyd S, Cookson N, Ballard CG, McKeith IG, Perry RH, Perry EK. Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication. Neuroscience. 98: 79-87. PMID 10858614 DOI: 10.1016/S0306-4522(00)00071-3  0.366
2000 Ballard C, Neill D, O'Brien J, McKeith IG, Ince P, Perry R. Anxiety, depression and psychosis in vascular dementia: prevalence and associations. Journal of Affective Disorders. 59: 97-106. PMID 10837878 DOI: 10.1016/S0165-0327(99)00057-9  0.344
2000 O'Brien J, Perry R, Barber R, Gholkar A, Thomas A. The association between white matter lesions on magnetic resonance imaging and noncognitive symptoms. Annals of the New York Academy of Sciences. 903: 482-9. PMID 10818542 DOI: 10.1111/J.1749-6632.2000.Tb06403.X  0.348
2000 Perry E, Martin-Ruiz C, Lee M, Griffiths M, Johnson M, Piggott M, Haroutunian V, Buxbaum JD, Nãsland J, Davis K, Gotti C, Clementi F, Tzartos S, Cohen O, Soreq H, ... ... Perry R, et al. Nicotinic receptor subtypes in human brain ageing, Alzheimer and Lewy body diseases. European Journal of Pharmacology. 393: 215-22. PMID 10771016 DOI: 10.1016/S0014-2999(00)00064-9  0.392
2000 McKeith IG, Ballard CG, Perry RH, Ince PG, O'Brien JT, Neill D, Lowery K, Jaros E, Barber R, Thompson P, Swann A, Fairbairn AF, Perry EK. Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies. Neurology. 54: 1050-8. PMID 10720273 DOI: 10.1212/Wnl.54.5.1050  0.394
2000 Ballard C, McKeith I, O'Brien J, Kalaria R, Jaros E, Ince P, Perry R. Neuropathological substrates of dementia and depression in vascular dementia, with a particular focus on cases with small infarct volumes. Dementia and Geriatric Cognitive Disorders. 11: 59-65. PMID 10705161 DOI: 10.1159/000017215  0.349
2000 Xu W, Liu L, Emson P, Harrington CR, McKeith IG, Perry RH, Morris CM, Charles IG. The CCTTT polymorphism in the NOS2A gene is associated with dementia with Lewy bodies. Neuroreport. 11: 297-9. PMID 10674474 DOI: 10.1097/00001756-200002070-00015  0.365
2000 Gibson AM, Singleton AB, Smith G, Woodward R, McKeith IG, Perry RH, Ince PG, Ballard CG, Edwardson JA, Morris CM. Lack of association of the alpha2-macroglobulin locus on chromosome 12 in AD. Neurology. 54: 433-8. PMID 10668708 DOI: 10.1212/Wnl.54.2.433  0.33
2000 McAuley DF, Johnston GD, Marra C, Silveri MC, Gainotti G, Ólafsdóttir M, Skoog I, Marcusson J, Armstrong RA, Cairns NJ, Lantos PL, McGleenon BM, Passmore AP, Eckert GP, Maras A, ... ... Perry R, et al. APOE Genotype and Alzheimer´s Disease Dementia and Geriatric Cognitive Disorders. 11: 237-237. DOI: 10.1159/000017243  0.317
2000 Ballard C, Piggott M, Johnson M, Cairns N, Perry R, McKeith I, Jaros E, O'Brien J, Holmes C, Perry E. Delusions associated with elevated muscarinic binding in dementia with Lewy bodies Annals of Neurology. 48: 868-876. DOI: 10.1002/1531-8249(200012)48:6<868::Aid-Ana7>3.0.Co;2-0  0.431
1999 Neill D, Curran MD, Middleton D, Mawhinney H, Edwardson JA, McKeith I, Ballard C, Morris C, Ince P, Jaros E, Perry R. Risk for Alzheimer's disease in older late-onset cases is associated with HLA-DRB1*03. Neuroscience Letters. 275: 137-40. PMID 10568518 DOI: 10.1016/S0304-3940(99)00761-2  0.367
1999 Martin-Ruiz CM, Court JA, Molnar E, Lee M, Gotti C, Mamalaki A, Tsouloufis T, Tzartos S, Ballard C, Perry RH, Perry EK. Alpha4 but not alpha3 and alpha7 nicotinic acetylcholine receptor subunits are lost from the temporal cortex in Alzheimer's disease. Journal of Neurochemistry. 73: 1635-40. PMID 10501210 DOI: 10.1046/J.1471-4159.1999.0731635.X  0.315
1999 McKeith IG, Perry EK, Perry RH. Report of the second dementia with Lewy body international workshop: diagnosis and treatment. Consortium on Dementia with Lewy Bodies. Neurology. 53: 902-5. PMID 10496243 DOI: 10.1212/Wnl.53.5.902  0.339
1999 Piggott MA, Marshall EF, Thomas N, Lloyd S, Court JA, Jaros E, Burn D, Johnson M, Perry RH, McKeith IG, Ballard C, Perry EK. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution. Brain : a Journal of Neurology. 122: 1449-68. PMID 10430831 DOI: 10.1093/Brain/122.8.1449  0.398
1999 Ballard C, Holmes C, McKeith I, Neill D, O'Brien J, Cairns N, Lantos P, Perry E, Ince P, Perry R. Psychiatric morbidity in dementia with Lewy bodies: a prospective clinical and neuropathological comparative study with Alzheimer's disease. The American Journal of Psychiatry. 156: 1039-45. PMID 10401449 DOI: 10.1176/Ajp.156.7.1039  0.423
1999 Singleton AB, Gibson AM, McKeith IG, Ballard CA, Perry RH, Ince PG, Edwardson JA, Morris CM. Alpha2-macroglobulin polymorphisms in Alzheimer's disease and dementia with Lewy bodies. Neuroreport. 10: 1507-10. PMID 10380971 DOI: 10.1097/00001756-199905140-00021  0.39
1999 Barber R, Scheltens P, Gholkar A, Ballard C, McKeith I, Ince P, Perry R, O'Brien J. White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging. Journal of Neurology, Neurosurgery, and Psychiatry. 67: 66-72. PMID 10369824 DOI: 10.1136/Jnnp.67.1.66  0.434
1999 Perry E, Walker M, Grace J, Perry R. Acetylcholine in mind: A neurotransmitter correlate of consciousness? Trends in Neurosciences. 22: 273-280. PMID 10354606 DOI: 10.1016/S0166-2236(98)01361-7  0.418
1999 Atkinson A, Singleton AB, Steward A, Ince PG, Perry RH, McKeith IG, Fairbairn AF, Edwardson JA, Daly AK, Morris CM. CYP2D6 is associated with Parkinson's disease but not with dementia with Lewy Bodies or Alzheimer's disease. Pharmacogenetics. 9: 31-5. PMID 10208640 DOI: 10.1097/00008571-199902000-00005  0.306
1999 Middleton D, Mawhinney H, Curran MD, Edwardson JA, Perry R, McKeith I, Morris C, Ince PG, Neill D. Frequency of HLA-A and B alleles in early and late-onset Alzheimer's disease. Neuroscience Letters. 262: 140-2. PMID 10203251 DOI: 10.1016/S0304-3940(99)00045-2  0.321
1999 Briel RC, McKeith IG, Barker WA, Hewitt Y, Perry RH, Ince PG, Fairbairn AF. EEG findings in dementia with Lewy bodies and Alzheimer's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 66: 401-3. PMID 10084544 DOI: 10.1136/Jnnp.66.3.401  0.4
1999 Harvey GT, Hughes J, McKeith IG, Briel R, Ballard C, Gholkar A, Scheltens P, Perry RH, Ince P, O'Brien JT. Magnetic resonance imaging differences between dementia with Lewy bodies and Alzheimer's disease: a pilot study. Psychological Medicine. 29: 181-7. PMID 10077306 DOI: 10.1017/S0033291798007806  0.406
1999 Goodchild RE, Court JA, Hobson I, Piggott MA, Perry RH, Ince P, Jaros E, Perry EK. Distribution of histamine H3-receptor binding in the normal human basal ganglia: comparison with Huntington's and Parkinson's disease cases. The European Journal of Neuroscience. 11: 449-56. PMID 10051746 DOI: 10.1046/J.1460-9568.1999.00453.X  0.364
1999 Ballard CG, Ayre G, O'Brien J, Sahgal A, McKeith IG, Ince PG, Perry RH. Simple standardised neuropsychological assessments aid in the differential diagnosis of dementia with Lewy bodies from Alzheimer's disease and vascular dementia. Dementia and Geriatric Cognitive Disorders. 10: 104-8. PMID 10026383 DOI: 10.1159/000017109  0.399
1999 Goodchild RE, Court JA, Hobson I, Piggott MA, Perry RH, Ince P, Jaros E, Perry EK. Distribution of histamine H3-receptor binding in the normal human basal ganglia: comparison with Huntington's disease and Parkinson's disease cases Biochemical Society Transactions. 27. DOI: 10.1042/Bst027A033  0.365
1998 Ballard CG, O'Brien J, Lowery K, Ayre GA, Harrison R, Perry R, Ince P, Neill D, McKeith IG. A prospective study of dementia with Lewy bodies. Age and Ageing. 27: 631-6. PMID 12675102 DOI: 10.1093/Ageing/27.5.631  0.383
1998 Perry E, Court J, Goodchild R, Griffiths M, Jaros E, Johnson M, Lloyd S, Piggott M, Spurden D, Ballard C, McKeith I, Perry R. Clinical neurochemistry: developments in dementia research based on brain bank material Journal of Neural Transmission. 105: 915-933. PMID 9869326 DOI: 10.1007/S007020050102  0.428
1998 McKeith IG, Ince P, Jaros EB, Fairbairn A, Ballard C, Grace J, Morris CM, Perry RH. What are the relations between Lewy body disease and AD? Journal of Neural Transmission. Supplementum. 54: 107-16. PMID 9850919 DOI: 10.1007/978-3-7091-7508-8_10  0.435
1998 Piggott MA, Perry EK, Marshall EF, McKeith IG, Johnson M, Melrose HL, Court JA, Lloyd S, Fairbairn A, Brown A, Thompson P, Perry RH. Nigrostriatal dopaminergic activities in dementia with Lewy bodies in relation to neuroleptic sensitivity: comparisons with Parkinson's disease. Biological Psychiatry. 44: 765-74. PMID 9798081 DOI: 10.1016/S0006-3223(98)00127-9  0.356
1998 Lyras L, Perry RH, Perry EK, Ince PG, Jenner A, Jenner P, Halliwell B. Oxidative damage to proteins, lipids, and DNA in cortical brain regions from patients with dementia with Lewy bodies. Journal of Neurochemistry. 71: 302-12. PMID 9648879 DOI: 10.1046/J.1471-4159.1998.71010302.X  0.352
1998 Singleton AB, Smith G, Gibson AM, Woodward R, Perry RH, Ince PG, Edwardson JA, Morris CM. No association between the K variant of the butyrylcholinesterase gene and pathologically confirmed Alzheimer's disease. Human Molecular Genetics. 7: 937-9. PMID 9536100 DOI: 10.1093/Hmg/7.5.937  0.353
1998 Lamb H, Christie J, Singleton AB, Leake A, Perry RH, Ince PG, McKeith IG, Melton LM, Edwardson JA, Morris CM. Apolipoprotein E and alpha-1 antichymotrypsin polymorphism genotyping in Alzheimer's disease and in dementia with Lewy bodies. Distinctions between diseases. Neurology. 50: 388-91. PMID 9484359 DOI: 10.1212/Wnl.50.2.388  0.392
1997 Ballard C, McKeith I, Harrison R, O'Brien J, Thompson P, Lowery K, Perry R, Ince P. A detailed phenomenological comparison of complex visual hallucinations in dementia with Lewy bodies and Alzheimer's disease. International Psychogeriatrics / Ipa. 9: 381-8. PMID 9549588 DOI: 10.1017/S1041610297004523  0.418
1997 Perry R, McKeith I, Perry E. Lewy body dementia — clinical, pathological and neurochemical interconnections Journal of Neural Transmission-Supplement. 51: 95-109. PMID 9470131 DOI: 10.1007/978-3-7091-6846-2_8  0.436
1997 Ballard C, McKeith I, Burn D, Harrison R, O'Brien J, Lowery K, Campbell M, Perry R, Ince P. The UPDRS scale as a means of identifying extrapyramidal signs in patients suffering from dementia with Lewy bodies. Acta Neurologica Scandinavica. 96: 366-71. PMID 9449473 DOI: 10.1111/J.1600-0404.1997.Tb00299.X  0.357
1997 Singleton AB, Lamb H, Leake A, McKeith IG, Ince PG, Perry RH, Morris CM. No association between a polymorphism in the presenilin 1 gene and dementia with Lewy bodies. Neuroreport. 8: 3637-9. PMID 9427340 DOI: 10.1097/00001756-199711100-00042  0.377
1997 Singleton AB, Lamb H, Leake A, McKeith IG, Perry RH, Morris CM. No association between an intronic polymorphism in the presenilin-1 gene and Alzheimer's disease. Neuroscience Letters. 234: 19-22. PMID 9347936 DOI: 10.1016/S0304-3940(97)00653-8  0.335
1997 Spurden DP, Court JA, Lloyd S, Oakley A, Perry R, Pearson C, Pullen RG, Perry EK. Nicotinic receptor distribution in the human thalamus: autoradiographical localization of [3H]nicotine and [125I] alpha-bungarotoxin binding. Journal of Chemical Neuroanatomy. 13: 105-13. PMID 9285355 DOI: 10.1016/S0891-0618(97)00038-0  0.32
1997 Marshall EF, Perry RH, Perry EK, Piggott MA, Thompson P, Jaros E, Burn DJ. Striatal dopaminergic loss without parkinsonism in a case of corticobasal degeneration. Acta Neurologica Scandinavica. 95: 287-92. PMID 9188904 DOI: 10.1111/J.1600-0404.1997.Tb00212.X  0.327
1997 Curran M, Middleton D, Edwardson J, Perry R, McKeith I, Morris C, Neill D. HLA-DR antigens associated with major genetic risk for late-onset Alzheimer's disease. Neuroreport. 8: 1467-1469. PMID 9172155 DOI: 10.1097/00001756-199704140-00028  0.353
1996 McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, ... ... Perry RH, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology. 47: 1113-24. PMID 8909416 DOI: 10.1212/Wnl.47.5.1113  0.442
1996 Morris CM, Massey HM, Benjamin R, Leake A, Broadbent C, Griffiths M, Lamb H, Brown A, Ince PG, Tyrer S, Thompson P, McKeith IG, Edwardson JA, Perry RH, Perry EK. Molecular biology of APO E alleles in Alzheimer's and non-Alzheimer's dementias. Journal of Neural Transmission. Supplementum. 47: 205-18. PMID 8841967 DOI: 10.1007/978-3-7091-6892-9_14  0.345
1996 Johnson M, Perry RH, Piggott MA, Court JA, Spurden D, Lloyd S, Ince PG, Perry EK. Glutamate receptor binding in the human hippocampus and adjacent cortex during development and aging. Neurobiology of Aging. 17: 639-51. PMID 8832639 DOI: 10.1016/0197-4580(96)00064-4  0.306
1996 Perry EK, Court JA, Lloyd S, Johnson M, Griffiths MH, Spurden D, Piggott MA, Turner J, Perry RH. Beta-amyloidosis in normal aging and transmitter signaling in human temporal lobe. Annals of the New York Academy of Sciences. 777: 388-92. PMID 8624118 DOI: 10.1111/J.1749-6632.1996.Tb34450.X  0.359
1996 Royston MC, Mann D, Pickering-Brown S, Owen F, Perry R, Ragbavan R, Khin-Nu C, Tyner S, Day K, Crook R, Hardy J, Roberts GW. ApoE2 allele, Down's syndrome, and dementia Annals of the New York Academy of Sciences. 777: 255-259. PMID 8624094 DOI: 10.1111/J.1749-6632.1996.Tb34428.X  0.405
1996 McKeith IG, Perry RH, Perry EK, Ince PG. 640 Consensus criteria for the clinical diagnosis of dementia with Lewy bodies (DLB) Neurobiology of Aging. 17. DOI: 10.1016/S0197-4580(96)80642-7  0.341
1996 Piggott MA, Court JA, Perry EK, Lloyd S, Thomas NJ, Smith ZM, Johnson M, Perry RH, McKeith IG. Dopaminergic and nicotinic interactions in the human striatum in dementia with lewy bodies, chronic schizophrenia and Parkinson's disease European Neuropsychopharmacology. 6. DOI: 10.1016/0924-977X(96)83039-2  0.343
1995 Benjamin R, Leake A, Ince PG, Perry RH, McKeith IG, Edwardson JA, Morris CM. Effects of apolipoprotein E genotype on cortical neuropathology in senile dementia of the Lewy body and Alzheimer's disease. Neurodegeneration : a Journal For Neurodegenerative Disorders, Neuroprotection, and Neuroregeneration. 4: 443-8. PMID 8846238 DOI: 10.1006/Neur.1995.0053  0.359
1995 Strong C, Anderton BH, Perry RH, Perry EK, Ince PG, Lovestone S. Abnormally phosphorylated tau protein in senile dementia of Lewy body type and Alzheimer disease: evidence that the disorders are distinct. Alzheimer Disease and Associated Disorders. 9: 218-22. PMID 8749611 DOI: 10.1097/00002093-199500940-00008  0.421
1995 Perry EK, Perry RH. Acetylcholine and hallucinations: disease-related compared to drug-induced alterations in human consciousness. Brain and Cognition. 28: 240-58. PMID 8546852 DOI: 10.1006/Brcg.1995.1255  0.412
1995 Perry EK, Morris CM, Court JA, Cheng A, Fairbairn AF, McKeith IG, Irving D, Brown A, Perry RH. Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology. Neuroscience. 64: 385-95. PMID 7700528 DOI: 10.1016/0306-4522(94)00410-7  0.456
1995 Mantle D, Falkous G, Ishiura S, Perry RH, Perry EK. Comparison of cathepsin protease activities in brain tissue from normal cases and cases with Alzheimer's disease, Lewy body dementia, Parkinson's disease and Huntington's disease. Journal of the Neurological Sciences. 131: 65-70. PMID 7561949 DOI: 10.1016/0022-510X(95)00035-Z  0.43
1994 McKeith IG, Fairbairn AF, Bothwell RA, Moore PB, Ferrier IN, Thompson P, Perry RH. An evaluation of the predictive validity and inter-rater reliability of clinical diagnostic criteria for senile dementia of Lewy body type. Neurology. 44: 872-7. PMID 8190290 DOI: 10.1212/Wnl.44.5.872  0.377
1994 Griffiths PD, Perry RH, Crossman AR. A detailed anatomical analysis of neurotransmitter receptors in the putamen and caudate in Parkinson's disease and Alzheimer's disease. Neuroscience Letters. 169: 68-72. PMID 8047295 DOI: 10.1016/0304-3940(94)90358-1  0.364
1994 McKeith IG, Fairbairn AF, Perry RH, Thompson P. The clinical diagnosis and misdiagnosis of senile dementia of Lewy body type (SDLT). The British Journal of Psychiatry : the Journal of Mental Science. 165: 324-32. PMID 7994501 DOI: 10.1192/Bjp.165.3.324  0.372
1994 Clair DS, Norrman J, Perry R, Yates C, Wilcock G, Brookes A. Apolipoprotein E ϵ4 allele frequency in patients with Lewy body dementia, Alzheimer's disease and age-matched controls Neuroscience Letters. 176: 45-46. PMID 7970234 DOI: 10.1016/0304-3940(94)90867-2  0.417
1994 Harrington CR, Perry RH, Perry EK, Hurt J, McKeith IG, Roth M, Wischik CM. Senile dementia of Lewy body type and Alzheimer type are biochemically distinct in terms of paired helical filaments and hyperphosphorylated tau protein. Dementia (Basel, Switzerland). 5: 215-28. PMID 7951676 DOI: 10.1159/000106727  0.423
1994 Raghavan R, Khin-Nu C, Brown AG, Day KA, Tyrer SP, Ince PG, Perry EK, Perry RH. Gender differences in the phenotypic expression of Alzheimer's disease in Down's syndrome (trisomy 21). Neuroreport. 5: 1393-6. PMID 7919207 DOI: 10.1097/00001756-199406000-00026  0.307
1994 Rempfer R, Crook R, Houlden H, Duff K, Hutton M, Roberts GW, Raghavan R, Perry R, Hardy J. Parkinson's disease, but not Alzheimer's disease, Lewy body variant associated with mutant alleles at cytochrome P450 gene. Lancet. 344: 815. PMID 7916091 DOI: 10.1016/S0140-6736(94)92370-1  0.374
1994 Benjamin R, Leake A, Edwardson JA, McKeith IG, Ince PG, Perry RH, Morris CM. Apolipoprotein E genes in Lewy body and Parkinson's disease. Lancet. 343: 1565. PMID 7911882 DOI: 10.1016/S0140-6736(94)92961-0  0.322
1994 Hardy J, Crook R, Prihar G, Roberts G, Raghavan R, Perry R. Senile dementia of the Lewy body type has an apolipoprotein E epsilon 4 allele frequency intermediate between controls and Alzheimer's disease. Neuroscience Letters. 182: 1-2. PMID 7891871 DOI: 10.1016/0304-3940(94)90190-2  0.425
1994 Royston MC, Mann D, Pickering-Brown S, Owen F, Perry R, Raghavan R, Khin-Nu C, Tyrer S, Day K, Crook R. Apolipoprotein E epsilon 2 allele promotes longevity and protects patients with Down's syndrome from dementia. Neuroreport. 5: 2583-5. PMID 7696609 DOI: 10.1097/00001756-199412000-00044  0.381
1993 Raghavan R, Khin-Nu C, Brown A, Irving D, Ince PG, Day K, Tyrer SP, Perry RH. Detection of Lewy bodies in Trisomy 21 (Down's syndrome). The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 20: 48-51. PMID 8467429 DOI: 10.1017/S0317167100047405  0.413
1993 Kerwin JM, Morris CM, Johnson M, Perry RH, Perry EK. Hippocampal p75 nerve growth factor receptor immunoreactivity in development, normal aging and senescence. Acta Anatomica. 147: 216-22. PMID 8249566 DOI: 10.1159/000147507  0.316
1993 Court JA, Perry EK, Johnson M, Piggott MA, Kerwin JA, Perry RH, Ince PG. Regional patterns of cholinergic and glutamate activity in the developing and aging human brain. Brain Research. Developmental Brain Research. 74: 73-82. PMID 8104741 DOI: 10.1016/0165-3806(93)90085-O  0.323
1993 Perry EK, Piggott MA, Court JA, Johnson M, Perry RH. Transmitters in the developing and senescent human brain. Annals of the New York Academy of Sciences. 695: 69-72. PMID 7902056 DOI: 10.1111/J.1749-6632.1993.Tb23030.X  0.312
1993 Perry EK, Perry RH. Neurochemical pathology and therapeutic strategies in degenerative dementia International Review of Psychiatry. 5: 363-380. DOI: 10.3109/09540269309037799  0.41
1992 Perry EK, Johnson M, Kerwin JM, Piggott MA, Court JA, Shaw PJ, Ince PG, Brown A, Perry RH. Convergent cholinergic activities in aging and Alzheimer's disease. Neurobiology of Aging. 13: 393-400. PMID 1625768 DOI: 10.1016/0197-4580(92)90113-C  0.379
1992 Dedman DJ, Treffry A, Candy JM, Taylor GA, Morris CM, Bloxham CA, Perry RH, Edwardson JA, Harrison PM. Iron and aluminium in relation to brain ferritin in normal individuals and Alzheimer's-disease and chronic renal-dialysis patients. The Biochemical Journal. 287: 509-14. PMID 1445209 DOI: 10.1042/Bj2870509  0.344
1992 Kerwin JM, Morris CM, Perry RH, Perry EK. Hippocampal nerve growth factor receptor immunoreactivity in patients with Alzheimer's and Parkinson's disease. Neuroscience Letters. 143: 101-4. PMID 1436650 DOI: 10.1016/0304-3940(92)90242-Y  0.416
1992 Gentleman SM, Williams B, Royston MC, Jagoe R, Clinton J, Perry RH, Ince PG, Allsop D, Polak JM, Roberts GW. Quantification of beta A4 protein deposition in the medial temporal lobe: a comparison of Alzheimer's disease and senile dementia of the Lewy body type. Neuroscience Letters. 142: 9-12. PMID 1407727 DOI: 10.1016/0304-3940(92)90608-A  0.315
1992 McKeith IG, Perry RH, Fairbairn AF, Jabeen S, Perry EK. Operational criteria for senile dementia of Lewy body type (SDLT). Psychological Medicine. 22: 911-22. PMID 1362617 DOI: 10.1017/S0033291700038484  0.427
1992 McKeith I, Fairbairn A, Perry R, Thompson P, Perry E. Neuroleptic sensitivity in patients with senile dementia of Lewy body type. Bmj. 305: 673-678. PMID 1356550 DOI: 10.1136/Bmj.305.6855.673  0.375
1992 Piggott MA, Perry EK, Sahgal A, Perry RH. Examination of parameters influencing [3H]MK-801 binding in postmortem human cortex. Journal of Neurochemistry. 58: 1001-8. PMID 1346624 DOI: 10.1111/J.1471-4159.1992.Tb09354.X  0.331
1992 McKeith LG, Fairbairn AF, Perry RH. Clinical diagnostic criteria for lewy body dementia Dementia and Geriatric Cognitive Disorders. 3: 251-252. DOI: 10.1159/000107025  0.329
1992 Jabeen S, McKeith IG, Fairbairn AF, Perry RH, Ferrier IN. Psychotic symptoms in Alzheimer's disease International Journal of Geriatric Psychiatry. 7: 341-345. DOI: 10.1002/Gps.930070506  0.363
1991 Xuereb JH, Perry RH, Candy JM, Perry EK, Marshall E, Bonham JR. Nerve cell loss in the thalamus in Alzheimer's disease and Parkinson's disease. Brain : a Journal of Neurology. 114: 1363-79. PMID 2065255 DOI: 10.1093/Brain/114.3.1363  0.42
1991 Ince P, Irving D, MacArthur F, Perry RH. Quantitative neuropathological study of Alzheimer-type pathology in the hippocampus: comparison of senile dementia of Alzheimer type, senile dementia of Lewy body type, Parkinson's disease and non-demented elderly control patients. Journal of the Neurological Sciences. 106: 142-52. PMID 1802962 DOI: 10.1016/0022-510X(91)90251-2  0.452
1991 Cheng AV, Ferrier IN, Morris CM, Jabeen S, Sahgal A, McKeith IG, Edwardson JA, Perry RH, Perry EK. Cortical serotonin-S2 receptor binding in Lewy body dementia, Alzheimer's and Parkinson's diseases. Journal of the Neurological Sciences. 106: 50-5. PMID 1779239 DOI: 10.1016/0022-510X(91)90193-B  0.381
1991 Leake A, Perry EK, Perry RH, Jabeen S, Fairbairn AF, McKeith IG, Ferrier IN. Neocortical concentrations of neuropeptides in senile dementia of the Alzheimer and Lewy body type: comparison with Parkinson's disease and severity correlations. Biological Psychiatry. 29: 357-64. PMID 1674664 DOI: 10.1016/0006-3223(91)90221-7  0.393
1991 Piggott MA, Candy JM, Perry RH. [3H]nitrendipine binding in temporal cortex in Alzheimer's and Huntington's diseases. Brain Research. 565: 42-7. PMID 1663418 DOI: 10.1016/0006-8993(91)91734-I  0.377
1990 Perry EK, Marshall E, Perry RH, Irving D, Smith CJ, Blessed G, Fairbairn AF. Cholinergic and dopaminergic activities in senile dementia of Lewy body type. Alzheimer Disease and Associated Disorders. 4: 87-95. PMID 2357341 DOI: 10.1097/00002093-199004020-00003  0.461
1990 Ghanbari HA, Miller BE, Haigler HJ, Arato M, Bissette G, Davies P, Nemeroff CB, Perry EK, Perry R, Ravid R. Biochemical assay of Alzheimer's disease--associated protein(s) in human brain tissue. A clinical study. Jama. 263: 2907-10. PMID 2187102 DOI: 10.1001/Jama.1990.03440210057032  0.424
1990 Xuereb JH, Tomlinson BE, Irving D, Perry RH, Blessed G, Perry EK. Cortical and subcortical pathology in Parkinson's disease: relationship to parkinsonian dementia. Advances in Neurology. 53: 35-40. PMID 2173374  0.308
1990 Leake A, Perry EK, Perry RH, Fairbairn AF, Ferrier IN. Cortical concentrations of corticotropin-releasing hormone and its receptor in Alzheimer type dementia and major depression. Biological Psychiatry. 28: 603-8. PMID 2171685 DOI: 10.1016/0006-3223(90)90398-L  0.368
1990 Perry RH, Irving D, Blessed G, Fairbairn A, Perry EK. Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly. Journal of the Neurological Sciences. 95: 119-39. PMID 2157823 DOI: 10.1016/0022-510X(90)90236-G  0.446
1990 Perry EK, Kerwin J, Perry RH, Blessed G, Fairbairn AF. Visual hallucinations and the cholinergic system in dementia. Journal of Neurology, Neurosurgery, and Psychiatry. 53: 88. PMID 2154559 DOI: 10.1136/Jnnp.53.1.88  0.308
1990 Xuereb JH, Candy JM, Perry EK, Perry RH, Marshall E, Bonham JR. Distribution of neurofibrillary tangle formation and [3H]-D-aspartate receptor binding in the thalamus in the normal elderly brain, in Alzheimer's disease and in Parkinson's disease. Neuropathology and Applied Neurobiology. 16: 477-88. PMID 1965733 DOI: 10.1111/J.1365-2990.1990.Tb01287.X  0.421
1990 Perry RH, Irving D, Tomlinson BE. Lewy body prevalence in the aging brain: relationship to neuropsychiatric disorders, Alzheimer-type pathology and catecholaminergic nuclei. Journal of the Neurological Sciences. 100: 223-33. PMID 1965207 DOI: 10.1016/0022-510X(90)90037-N  0.36
1990 Griffiths PD, Sambrook MA, Perry R, Crossman AR. Changes in benzodiazepine and acetylcholine receptors in the globus pallidus in Parkinson's disease. Journal of the Neurological Sciences. 100: 131-6. PMID 1965202 DOI: 10.1016/0022-510X(90)90023-G  0.356
1990 Xuereb JH, Perry EK, Candy JM, Bonham JR, Perry RH, Marshall E. Parameters of cholinergic neurotransmission in the thalamus in Parkinson's disease and Alzheimer's disease. Journal of the Neurological Sciences. 99: 185-97. PMID 1964958 DOI: 10.1016/0022-510X(90)90155-G  0.382
1990 Perry EK, Marshall E, Kerwin J, Smith CJ, Jabeen S, Cheng AV, Perry RH. Evidence of a monoaminergic-cholinergic imbalance related to visual hallucinations in Lewy body dementia. Journal of Neurochemistry. 55: 1454-6. PMID 1697897 DOI: 10.1111/J.1471-4159.1990.Tb03162.X  0.401
1990 Perry EK, Kerwin J, Perry RH, Irving D, Blessed G, Fairbairn A. Cerebral Cholinergic Activity Is Related to the Incidence of Visual Hallucinations in Senile Dementia of Lewy Body Type Dementia and Geriatric Cognitive Disorders. 1: 2-4. DOI: 10.1159/000107114  0.347
1989 Mantle D, Lauffart B, Perry EK, Perry RH. Comparison of major cortical aminopeptidase activity in normal brain and brain from patients with Alzheimer's disease. Journal of the Neurological Sciences. 89: 227-34. PMID 2926450 DOI: 10.1016/0022-510X(89)90024-5  0.385
1989 Perry EK, Perry R. Amyloid and Alzheimer's disease: a question of specificity. Neurobiology of Aging. 10: 473-4; discussion 47. PMID 2682325 DOI: 10.1016/0197-4580(89)90103-6  0.352
1989 Perry RH, Irving D, Blessed G, Perry EK, Fairbairn AF. Senile dementia of Lewy body type and spectrum of Lewy body disease. Lancet. 1: 1088. PMID 2566043 DOI: 10.1016/S0140-6736(89)92492-6  0.361
1989 Perry RH, Irving D, Blessed G, Perry EK, Fairbairn AF. Clinically and neuropathologically distinct form of dementia in the elderly. Lancet. 1: 166. PMID 2563086 DOI: 10.1016/S0140-6736(89)91187-2  0.344
1988 Smith CJ, Perry EK, Perry RH, Candy JM, Johnson M, Bonham JR, Dick DJ, Fairbairn A, Blessed G, Birdsall NJ. Muscarinic cholinergic receptor subtypes in hippocampus in human cognitive disorders. Journal of Neurochemistry. 50: 847-56. PMID 3339358 DOI: 10.1111/J.1471-4159.1988.Tb02990.X  0.427
1988 Whitford C, Candy J, Edwardson J, Perry R. Cortical somatostatinergic system not affected in Alzheimer's and Parkinson's diseases. Journal of the Neurological Sciences. 86: 13-18. PMID 2902199 DOI: 10.1016/0022-510X(88)90003-2  0.449
1987 Smith CJ, Perry EK, Perry RH, Fairbairn AF, Birdsall NJ. Guanine nucleotide modulation of muscarinic cholinergic receptor binding in postmortem human brain--a preliminary study in Alzheimer's disease. Neuroscience Letters. 82: 227-32. PMID 3696495 DOI: 10.1016/0304-3940(87)90135-2  0.378
1987 Court J, Ferrier N, Griffiths H, Lauffart B, Perry R, Candy J, Fairbairn A, Blessed G. Serum creatine kinase-BB levels and cerebral cortical creatine kinase activity in senile dementia of the Alzheimer type. Journal of the Neurological Sciences. 80: 111-115. PMID 3612178 DOI: 10.1016/0022-510X(87)90225-5  0.376
1987 Atack JR, Perry EK, Bonham JR, Candy JM, Perry RH. Molecular forms of butyrylcholinesterase in the human neocortex during development and degeneration of the cortical cholinergic system. Journal of Neurochemistry. 48: 1687-92. PMID 3572398 DOI: 10.1111/J.1471-4159.1987.Tb05724.X  0.352
1987 Perry EK, Perry RH, Smith CJ, Dick DJ, Candy JM, Edwardson JA, Fairbairn A, Blessed G. Nicotinic receptor abnormalities in Alzheimer's and Parkinson's diseases. Journal of Neurology, Neurosurgery, and Psychiatry. 50: 806-9. PMID 2956364 DOI: 10.1136/Jnnp.50.6.806  0.384
1987 Cross AJ, Slater P, Simpson M, Royston C, Deakin JF, Perry RH, Perry EK. Sodium dependent D-[3H]aspartate binding in cerebral cortex in patients with Alzheimer's and Parkinson's diseases. Neuroscience Letters. 79: 213-7. PMID 2823192 DOI: 10.1016/0304-3940(87)90699-9  0.356
1987 Taylor GR, Carter GI, Crow TJ, Johnson JA, Fairbairn AF, Perry EK, Perry RH. Recovery and measurement of RNA in Alzheimer's disease by molecular hybridisation. Journal of Neurology, Neurosurgery, and Psychiatry. 50: 356. PMID 2435853 DOI: 10.1136/Jnnp.50.3.356  0.316
1987 Cross A, Slater P, Candy J, Perry E, Perry R. Glutamate deficits in Alzheimer's disease Journal of Neurology, Neurosurgery, and Psychiatry. 50: 357-358. DOI: 10.1136/Jnnp.50.3.357  0.363
1987 Morris CM, Court JA, Moshtaghie AA, Skillen A, Candy JM, Perry RH, Edwardson JA, Fairbairn A. Transferrin and transferrin receptors in normal brain and in Alzheimer's disease Biochemical Society Transactions. 15: 891-892. DOI: 10.1042/Bst0150891  0.386
1986 Perry EK, Perry RH, Smith CJ, Purohit D, Bonham J, Dick DJ, Candy JM, Edwardson JA, Fairbairn A. Cholinergic receptors in cognitive disorders. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 13: 521-7. PMID 3791066 DOI: 10.1017/S0317167100037240  0.413
1986 Perry EK, Smith CJ, Atack JR, Candy JM, Johnson M, Perry RH. Neocortical cholinergic enzyme and receptor activities in the human fetal brain. Journal of Neurochemistry. 47: 1262-9. PMID 3746300 DOI: 10.1111/J.1471-4159.1986.Tb00749.X  0.326
1986 Candy JM, Perry EK, Perry RH, Court JA, Oakley AE, Edwardson JA. The current status of the cortical cholinergic system in Alzheimer's disease and Parkinson's disease. Progress in Brain Research. 70: 105-32. PMID 3554348 DOI: 10.1016/S0079-6123(08)64300-9  0.436
1986 Candy JM, Oakley AE, Klinowski J, Carpenter TA, Perry RH, Atack JR, Perry EK, Blessed G, Fairbairn A, Edwardson JA. Aluminosilicates and senile plaque formation in Alzheimer's disease. Lancet. 1: 354-7. PMID 2868298 DOI: 10.1097/00002093-198701000-00047  0.388
1986 Taylor GR, Carter GI, Crow TJ, Johnson JA, Fairbairn AF, Perry EK, Perry RH. Recovery and measurement of specific RNA species from postmortem brain tissue: a general reduction in Alzheimer's disease detected by molecular hybridization. Experimental and Molecular Pathology. 44: 111-6. PMID 2419156 DOI: 10.1016/0014-4800(86)90038-9  0.339
1986 Perry EK, Perry RH. CNS cholinergic markers and Alzheimer's disease Neurobiology of Aging. 7: 390-391. DOI: 10.1016/0197-4580(86)90167-3  0.391
1986 Perry EK, Perry RH. Unfolding the nature of senile plaque amyloid Neurobiology of Aging. 7: 437-439. DOI: 10.1016/0197-4580(86)90058-8  0.367
1985 Candy JM, Perry EK, Perry RH, Bloxham CA, Thompson J, Johnson M, Oakley AE, Edwardson JA. Evidence for the early prenatal development of cortical cholinergic afferents from the nucleus of Meynert in the human foetus. Neuroscience Letters. 61: 91-5. PMID 4080261 DOI: 10.1016/0304-3940(85)90406-9  0.309
1985 Atack JR, Perry EK, Perry RH, Wilson ID, Bober MJ, Blessed G, Tomlinson BE. Blood acetyl- and butyrylcholinesterases in senile dementia of Alzheimer type. Journal of the Neurological Sciences. 70: 1-12. PMID 4045496 DOI: 10.1016/0022-510X(85)90182-0  0.326
1985 Perry EK, Curtis M, Dick DJ, Candy JM, Atack JR, Bloxham CA, Blessed G, Fairbairn A, Tomlinson BE, Perry RH. Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 48: 413-21. PMID 3998751 DOI: 10.1136/Jnnp.48.5.413  0.448
1985 Candy JM, Gascoigne AD, Biggins JA, Smith AI, Perry RH, Perry EK, McDermott JR, Edwardson JA. Somatostatin immunoreactivity in cortical and some subcortical regions in Alzheimer's disease. Journal of the Neurological Sciences. 71: 315-23. PMID 2868073 DOI: 10.1016/0022-510X(85)90070-X  0.377
1985 Perry EK, Perry RH. New insights into the nature of senile (Alzheimer-type) plaques Trends in Neurosciences. 8: 301-303. DOI: 10.1016/0166-2236(85)90107-9  0.386
1984 Cross AJ, Crow TJ, Johnson JA, Perry EK, Perry RH, Blessed G, Tomlinson BE. Studies on neurotransmitter receptor systems in neocortex and hippocampus in senile dementia of the Alzheimer-type. Journal of the Neurological Sciences. 64: 109-17. PMID 6747659 DOI: 10.1016/0022-510X(84)90029-7  0.384
1984 Perry EK, Perry RH, Candy JM, Fairbairn AF, Blessed G, Dick DJ, Tomlinson BE. Cortical serotonin-S2 receptor binding abnormalities in patients with Alzheimer's disease: comparisons with Parkinson's disease. Neuroscience Letters. 51: 353-7. PMID 6521962 DOI: 10.1016/0304-3940(84)90402-6  0.416
1984 Perry EK, Atack JR, Perry RH, Hardy JA, Dodd PR, Edwardson JA, Blessed G, Tomlinson BE, Fairbairn AF. Intralaminar neurochemical distributions in human midtemporal cortex: comparison between Alzheimer's disease and the normal. Journal of Neurochemistry. 42: 1402-10. PMID 6142924 DOI: 10.1111/J.1471-4159.1984.Tb02801.X  0.373
1983 Candy JM, Perry RH, Perry EK, Irving D, Blessed G, Fairbairn AF, Tomlinson BE. Pathological changes in the nucleus of Meynert in Alzheimer's and Parkinson's diseases. Journal of the Neurological Sciences. 59: 277-89. PMID 6854353 DOI: 10.1016/0022-510X(83)90045-X  0.419
1983 Perry EK, Marshall EF, Blessed G, Tomlinson BE, Perry RH. Decreased imipramine binding in the brains of patients with depressive illness. The British Journal of Psychiatry : the Journal of Mental Science. 142: 188-92. PMID 6839075 DOI: 10.1192/Bjp.142.2.188  0.305
1983 Atack JR, Perry EK, Bonham JR, Perry RH, Tomlinson BE, Blessed G, Fairbairn A. Molecular forms of acetylcholinesterase in senile dementia of Alzheimer type: selective loss of the intermediate (10S) form. Neuroscience Letters. 40: 199-204. PMID 6633975 DOI: 10.1016/0304-3940(83)90302-6  0.373
1983 Biggins JA, Perry EK, McDermott JR, Smith AI, Perry RH, Edwardson JA. Post mortem levels of thyrotropin-releasing hormone and neurotensin in the amygdala in Alzheimer's disease, schizophrenia and depression. Journal of the Neurological Sciences. 58: 117-22. PMID 6405015 DOI: 10.1016/0022-510X(83)90114-4  0.344
1983 Cross AJ, Crow TJ, Johnson JA, Joseph MH, Perry EK, Perry RH, Blessed G, Tomlinson BE. Monoamine metabolism in senile dementia of Alzheimer type. Journal of the Neurological Sciences. 60: 383-92. PMID 6195313 DOI: 10.1016/0022-510X(83)90149-1  0.366
1983 Biggins JA, Perry RH, Candy JM, Perry EK, Bloxham CA, Johnson M, Edwardson JA. Neurotensin immunoreactivity and choline acetyltransferase activity in the cerebral cortex in Parkinson's disease Regulatory Peptides. 7: 277. DOI: 10.1016/0167-0115(83)90034-4  0.359
1982 Tomlinson B, Perry R. Genetics of Alzheimer's disease Bmj. 285: 58-59. DOI: 10.1136/Bmj.285.6334.58-E  0.35
1982 Perry EE, Perry RH. The cholinergic system in Alzheimer's disease Trends in Neurosciences. 5: 261-262. DOI: 10.1016/0166-2236(82)90165-5  0.443
1981 Perry EK, Tomlinson BE, Blessed G, Perry RH, Cross AJ, Crow TJ. Neuropathological and biochemical observations on the noradrenergic system in Alzheimer's disease. Journal of the Neurological Sciences. 51: 279-87. PMID 7276979 DOI: 10.1016/0022-510X(81)90106-4  0.432
1981 Cross AJ, Crow TJ, Perry EK, Perry RH, Blessed G, Tomlinson BE. Reduced dopamine-beta-hydroxylase activity in Alzheimer's disease. British Medical Journal (Clinical Research Ed.). 282: 93-4. PMID 6779929 DOI: 10.1136/Bmj.282.6258.93  0.369
1981 Perry RH, Dockray GJ, Dimaline R, Perry EK, Blessed G, Tomlinson BE. Neuropeptides in Alzheimer's disease, depression and schizophrenia. A post mortem analysis of vasoactive intestinal peptide and cholecystokinin in cerebral cortex. Journal of the Neurological Sciences. 51: 465-72. PMID 6268760 DOI: 10.1016/0022-510X(81)90123-4  0.374
1981 Perry EK, Blessed G, Tomlinson BE, Perry RH, Crow TJ, Cross AJ, Dockray GJ, Dimaline R, Arregui A. Neurochemical activities in human temporal lobe related to aging and Alzheimer-type changes. Neurobiology of Aging. 2: 251-6. PMID 6174877 DOI: 10.1016/0197-4580(81)90032-4  0.418
1980 Tarbit I, Perry EK, Perry RH, Blessed G, Tomlinson BE. Hippocampal free amino acids in Alzheimer's disease. Journal of Neurochemistry. 35: 1246-9. PMID 7452316 DOI: 10.1111/J.1471-4159.1980.Tb07883.X  0.344
1980 Perry RH, Blessed G, Perry EK, Tomlinson BE. Histochemical observations on cholinesterase activities in the brains of elderly normal and demented (Alzheimer-type) patients. Age and Ageing. 9: 9-16. PMID 7370097 DOI: 10.1093/Ageing/9.1.9  0.413
1980 Perry EK, Perry RH, Tomlinson BE, Blessed G, Gibson PH. Coenzyme A-acetylating enzymes in Alzheimer's disease: possible cholinergic 'compartment' of pyruvate dehydrogenase. Neuroscience Letters. 18: 105-10. PMID 6133246 DOI: 10.1016/0304-3940(80)90220-7  0.374
1980 Sanders D, Zahedi-Asl S, Lund P, Marr A, Perry E, Perry R. CCK immunoreactivity in human cerebral cortical grey and white matter in health and disease Regulatory Peptides. 1. DOI: 10.1016/0167-0115(80)90213-X  0.301
1978 Perry EK, Tomlinson BE, Blessed G, Bergmann K, Gibson PH, Perry RH. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. British Medical Journal. 2: 1457-9. PMID 719462 DOI: 10.1136/Bmj.2.6150.1457  0.411
1978 Perry EK, Perry RH, Blessed G, Tomlinson BE. Changes in brain cholinesterases in senile dementia of Alzheimer type. Neuropathology and Applied Neurobiology. 4: 273-7. PMID 703927 DOI: 10.1111/J.1365-2990.1978.Tb00545.X  0.438
1977 Perry EK, Perry RH, Gibson PH, Blessed G, Tomlinson BE. A cholinergic connection between normal aging and senile dementia in the human hippocampus. Neuroscience Letters. 6: 85-9. PMID 19605034 DOI: 10.1016/0304-3940(77)90070-2  0.378
1977 Perry EK, Perry RH, Tomlinson BE. Circadian variations in cholinergic enzymes and muscarinic receptor binding in human cerebral cortex. Neuroscience Letters. 4: 185-9. PMID 19604942 DOI: 10.1016/0304-3940(77)90136-7  0.319
1977 Perry EK, Gibson PH, Blessed G, Perry RH, Tomlinson BE. Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue. Journal of the Neurological Sciences. 34: 247-65. PMID 144789 DOI: 10.1016/0022-510X(77)90073-9  0.361
Show low-probability matches.